Science - USA (2021-12-17)

Research Funding Available

Up to $1M per lab

Proposals due March 1, 2022

Ionis is funding investigators with extraordinarily

original ideas to identify next-wave technologies

for healthcare through its Ion-ARPA program.

The current program announcement“Novel

Therapeutic Payloads”is for proposals to develop

non-conventional technologies to modulate the

expression of mammalian genes to overcome a

diseased state. General areas of interest include, but

are not limited to, novel strategies for silencing or

activating genes and gene editing beyond existing

CRISPR/Cas9- or deaminase-based approaches.

TO ACCESS MORE INFORMATION SEE:

http://www.ionispharma.com/ionis-innovation/ion-arpa-initiative/

Keep moving forward in the

fight against COVID-19 and

learn about our offerings by

scanning the QR code above.

Accuracy and reliability—advanced assay designs compensate for current

and emerging mutations like the Delta (B.1.617.2) and Alpha (B.1.1.7) variants

Service partnerships—help ensure minimal downtime, allowing operations

to continue running at their peak

Single-source convenience—one supplier reliably providing all

consumables, instruments, and servicing to enable uninterrupted testing

Partner with the global leader involved in over 50% of COVID-19 testing to

help solve the most intractable crisis we face today.

Weoffer:

© 2021 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific

and its subsidiaries unless otherwise specified.COL25296 0721

Getafreeinfographiconlab-basedandrapidPCRtestingat

thermofisher.com/covid19scienceinfographic

Get answers. Keep moving.

1217Product.indd 1453 12/9/21 7:51 AM